Anavex Life Sciences Corp (AVXL)

[Pineapple1]

AVXL stock price to Alexion's

Agreed Dr Missling (Anavex) should not have any trouble getting to the same

market cap as Alexion, which would be a $63 price for our stock. Especially

considering the increase in market value (15B) of Biogen with their

announcement that the FDA will let them submit for an NDA even with

brain swelling. It would be fun to be at CTAD next week when Biogen gives

their presentation on their drug; would love to ask them a few questions.

Wonder if the market will sell off after the presentation.

11.15 a.m LATE BREAKING ORAL COMMUNICATION Chairs: Philip Scheltens, Alette Wessels LB10 - Persistence Of BAN2401-Mediated Amyloid Reductions Post-Treatment: A Preliminary Comparison Of Amyloid Status Between The Core Phase Of BAN2401-G000-201 And Baseline Of The Open-Label Extension Phase In Subjects With Early Alzheimer’s Disease Chad Swanson (1), Yong Zhang (1), Shobha Dhadda (1), Jinping Wang (1), June Kaplow (1), Heather Bradley (1), Martin Rabe (1), Keiichiro Totsuka (2), Robert Lai (3), Robert Gordon (3), Lynn Kramer (1) (1) Eisai Inc., United States, (2) Eisai Co., Ltd., Japan, (3) Eisai Ltd., United Kingdom